iBio (IBIO) EBITDA (2010 - 2026)
iBio (IBIO) reported EBITDA of -$11.23 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$5.07 million a year earlier.
Analysis
iBio (IBIO) EBITDA (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio posted EBITDA of -$34.56 million.
- By fiscal year, EBITDA came in at -$18.1 million in FY2025, -$15.86 million in FY2024, -$28.3 million in FY2023 and -$27.02 million in FY2022.
- The fiscal Q4 2026 figure ranks as the lowest quarterly EBITDA in data going back to fiscal Q1 2011.
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$8.21 million (Q3 2026), -$9.3 million (Q2 2026) and -$5.82 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | iBio | 87.72 Mn | -177.49 Mn | - | -11.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.23 Mn |
| Mar 31, 2026 | -8.21 Mn |
| Dec 31, 2025 | -9.30 Mn |
| Sep 30, 2025 | -5.76 Mn |
| Jun 30, 2025 | -5.00 Mn |
| Mar 31, 2025 | -4.69 Mn |
| Dec 31, 2024 | -4.22 Mn |
| Sep 30, 2024 | -3.91 Mn |
| Jun 30, 2024 | -3.19 Mn |
| Mar 31, 2024 | -3.39 Mn |
| Dec 31, 2023 | -4.26 Mn |
| Sep 30, 2023 | -4.84 Mn |
| Jun 30, 2023 | -4.71 Mn |
| Mar 31, 2023 | -5.98 Mn |
| Dec 31, 2022 | -10.33 Mn |
| Sep 30, 2022 | -7.26 Mn |
| Jun 30, 2022 | -9.63 Mn |
| Mar 31, 2022 | -5.88 Mn |
| Dec 31, 2021 | -6.50 Mn |
| Sep 30, 2021 | -4.42 Mn |
API Access
iBio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=IBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();